Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug combinations in syringe drivers

I Lichter, E Hunt

    The New Zealand Medical Journal
    |June 14, 1995
    PubMed
    Summary
    This summary is machine-generated.

    This study found that many drug combinations are compatible in syringe drivers for continuous subcutaneous infusion, enabling effective symptom control in terminal illness. Skin reactions were minimal and related to the number of drugs combined.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Racial and Ethnic Representation in Nephrolithiasis Guidelines: Are They Generalizable?

    Urology·2024
    Same author

    Examining Motivation of First-Year Undergraduate Anatomy Students Through the Lens of Universal Design for Learning (UDL): A Single Institution Study.

    Medical science educator·2023
    Same author

    A feasibility study on a novel well-being intervention for university students.

    Irish journal of psychological medicine·2021
    Same author

    Genetic and environmental overlap between borderline personality disorder traits and psychopathy: evidence for promotive effects of factor 2 and protective effects of factor 1.

    Psychological medicine·2014
    Same author

    SOAR as a world view, not a theory.

    The Behavioral and brain sciences·2014
    Same author

    TRiM: an organizational response to traumatic events in Cumbria Constabulary.

    Occupational medicine (Oxford, England)·2013
    Same journal

    Reed diffusers: a potential cause of poisoning in young children in New Zealand.

    The New Zealand medical journal·2026
    Same journal

    Stuffy nights: elevated bedroom carbon dioxide concentrations indicate inadequate ventilation in Wellington homes.

    The New Zealand medical journal·2026
    Same journal

    Cautionary tale of how sodium polystyrene sulfonate caused gut necrosis: a case report.

    The New Zealand medical journal·2026
    Same journal

    Emergency lateral canthotomy and cantholysis for acute globe subluxation.

    The New Zealand medical journal·2026
    Same journal

    Liberation of an incarcerated tibialis posterior tendon following a posterior malleolar ankle fracture: a case report.

    The New Zealand medical journal·2026
    Same journal

    Implementing a cultural safety training plan across medical colleges in Aotearoa New Zealand-looking back, and looking forward.

    The New Zealand medical journal·2026
    See all related articles

    Area of Science:

    • Palliative Care
    • Pharmacology
    • Oncology

    Background:

    • Continuous subcutaneous infusion via syringe drivers is crucial for symptom management in palliative care.
    • There is variability in understanding drug compatibility for these infusions.
    • Ensuring drug efficacy and safety in combination is essential.

    Purpose of the Study:

    • To document compatible drug combinations used in syringe drivers for continuous subcutaneous infusion.
    • To assess the clinical efficacy and incidence of skin reactions with various drug combinations.

    Main Methods:

    • Recorded the contents of syringe drivers in 100 consecutive palliative care patients.
    • Monitored for skin reactions associated with different administered drugs.
    • Clinically evaluated the efficacy of drug combinations.

    Related Experiment Videos

    Main Results:

    • A wide range of drug combinations were used with no observed loss of clinical efficacy.
    • Certain drug combinations were found to be incompatible.
    • Skin reactions were not observed with drugs known to cause them; incidence correlated with the number of drugs in the combination.

    Conclusions:

    • The compatibility of numerous medications in syringe drivers supports their use for managing diverse symptoms in terminal illness.
    • Further research is required for quantitative assessment of drug stability in these combinations.